2017 annual financial data
Seres Therapeutics 2017 Operating margin
Seres Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was -284.72%.
Operating income was -91,395,000 USD and net income was -89,380,000 USD.
Operating cash flow was -75,523,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 32,100,000 USD
- Operating income
- -91,395,000 USD
- Net income
- -89,380,000 USD
- Operating cash flow
- -75,523,000 USD